186 related articles for article (PubMed ID: 27530282)
1. The Effect of a Yeast Probiotic on Acute Diarrhea in Children.
Sharif MR; Kashani HH; Ardakani AT; Kheirkhah D; Tabatabaei F; Sharif A
Probiotics Antimicrob Proteins; 2016 Dec; 8(4):211-214. PubMed ID: 27530282
[TBL] [Abstract][Full Text] [Related]
2. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study.
Htwe K; Yee KS; Tin M; Vandenplas Y
Am J Trop Med Hyg; 2008 Feb; 78(2):214-6. PubMed ID: 18256417
[TBL] [Abstract][Full Text] [Related]
3. [A multicenter randomized controlled study of
Wan CM; Yu H; Liu G; Xu HM; Mao ZQ; Xu Y; Jin Y; Luo RP; Wang WJ; Fang F
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):349-354. PubMed ID: 28482385
[No Abstract] [Full Text] [Related]
4. Effects of Saccharomyces boulardii in children with acute diarrhoea.
Kurugöl Z; Koturoğlu G
Acta Paediatr; 2005 Jan; 94(1):44-7. PubMed ID: 15858959
[TBL] [Abstract][Full Text] [Related]
5. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea.
Billoo AG; Memon MA; Khaskheli SA; Murtaza G; Iqbal K; Saeed Shekhani M; Siddiqi AQ
World J Gastroenterol; 2006 Jul; 12(28):4557-60. PubMed ID: 16874872
[TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy Comparison of Saccharomyces Boulardii and Lactic Acid as Probiotics in Acute Pediatric Diarrhea.
Asmat S; Shaukat F; Asmat R; Bakhat HFSG; Asmat TM
J Coll Physicians Surg Pak; 2018 Mar; 28(3):214-217. PubMed ID: 29544579
[TBL] [Abstract][Full Text] [Related]
7. Probiotics for prevention and treatment of diarrhea.
Guandalini S
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study.
Eren M; Dinleyici EC; Vandenplas Y
Am J Trop Med Hyg; 2010 Mar; 82(3):488-91. PubMed ID: 20207879
[TBL] [Abstract][Full Text] [Related]
9. Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
Altcheh J; Carosella MV; Ceballos A; D'Andrea U; Jofre SM; Marotta C; Mugeri D; Sabbaj L; Soto A; Josse C; Montestruc F; McFarland LV
Medicine (Baltimore); 2022 Sep; 101(36):e30500. PubMed ID: 36086703
[TBL] [Abstract][Full Text] [Related]
10. Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.
Dinleyici EC; Kara A; Dalgic N; Kurugol Z; Arica V; Metin O; Temur E; Turel O; Guven S; Yasa O; Bulut S; Tanir G; Yazar AS; Karbuz A; Sancar M; Erguven M; Akca G; Eren M; Ozen M; Vandenplas Y
Benef Microbes; 2015; 6(4):415-21. PubMed ID: 25653151
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children.
Savaş-Erdeve S; Gökay S; Dallar Y
Turk J Pediatr; 2009; 51(3):220-4. PubMed ID: 19817264
[TBL] [Abstract][Full Text] [Related]
12. The probiotic effect of Saccharomyces boulardii in a pediatric age group.
Erdeve O; Tiras U; Dallar Y
J Trop Pediatr; 2004 Aug; 50(4):234-6. PubMed ID: 15357564
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute diarrhea with Saccharomyces boulardii in infants.
Corrêa NB; Penna FJ; Lima FM; Nicoli JR; Filho LA
J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):497-501. PubMed ID: 21734600
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections.
Shan LS; Hou P; Wang ZJ; Liu FR; Chen N; Shu LH; Zhang H; Han XH; Han XX; Cai XX; Shang YX; Vandenplas Y
Benef Microbes; 2013 Dec; 4(4):329-334. PubMed ID: 24311316
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
Kotowska M; Albrecht P; Szajewska H
Aliment Pharmacol Ther; 2005 Mar; 21(5):583-90. PubMed ID: 15740542
[TBL] [Abstract][Full Text] [Related]
16. Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study.
Villarruel G; Rubio DM; Lopez F; Cintioni J; Gurevech R; Romero G; Vandenplas Y
Acta Paediatr; 2007 Apr; 96(4):538-41. PubMed ID: 17306006
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea.
Dinleyici EC; Eren M; Ozen M; Yargic ZA; Vandenplas Y
Expert Opin Biol Ther; 2012 Apr; 12(4):395-410. PubMed ID: 22335323
[TBL] [Abstract][Full Text] [Related]
18. Systematic review with meta-analysis: Saccharomyces boulardii for treating acute gastroenteritis in children-a 2020 update.
Szajewska H; Kołodziej M; Zalewski BM
Aliment Pharmacol Ther; 2020 Apr; 51(7):678-688. PubMed ID: 32056266
[TBL] [Abstract][Full Text] [Related]
19. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.
Szajewska H; Skórka A; Dylag M
Aliment Pharmacol Ther; 2007 Feb; 25(3):257-64. PubMed ID: 17269987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
